Trade agreement threatens access to affordable medicines

Press Release – Global Asthma Network Access to affordable medicines is threatened by the proposed Trans Pacific Partnership Agreement, according to the New Zealand-based leader of the Global Asthma Network, Professor Innes Asher.For immediate release Trade agreement threatens access to affordable medicines Access to affordable medicines is threatened by the proposed Trans Pacific Partnership Agreement, according to the New Zealand-based leader of the Global Asthma Network, Professor Innes Asher. Media Release The University of Auckland 20th September 2013 Trade agreement threatens access to affordable medicines Access to affordable medicines is threatened by the proposed Trans Pacific Partnership Agreement, according to the New Zealand-based leader of the Global Asthma Network, Professor Innes Asher. The US-driven trade agreement is designed to promote the interests of the pharmaceutical industry to the great detriment of public health, says Professor Asher from the University of Auckland. “A lobby group influenced by the pharmaceutical industry is seeking to eliminate therapeutic reference pricing and introduce appeals processes that will allow pharmaceutical companies to challenge formulary listing and pricing decisions”, says Professor Asher. “It is also trying to introduce onerous disclosure and “transparency” provisions that will facilitate industry involvement in domestic decision-making around coverage, reimbursement and pricing of medicines and medical devices.” Professor Asher was referring to a paper published recently in the journal “Health Policy” * in which the authors describe how these proposed TPPA provisions...

Read More